Cargando…
Strategies for the Development of Conotoxins as New Therapeutic Leads
Peptide toxins typically bind to their target ion channels or receptors with high potency and selectivity, making them attractive leads for therapeutic development. In some cases the native peptide as it is found in the venom from which it originates can be used directly, but in many instances it is...
Autores principales: | Brady, Ryan M., Baell, Jonathan B., Norton, Raymond S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736424/ https://www.ncbi.nlm.nih.gov/pubmed/23812174 http://dx.doi.org/10.3390/md11072293 |
Ejemplares similares
-
µ-Conotoxins as Leads in the Development of New Analgesics
por: Norton, Raymond S.
Publicado: (2010) -
Conotoxin Gene Superfamilies
por: Robinson, Samuel D., et al.
Publicado: (2014) -
Conotoxins that Confer Therapeutic Possibilities
por: Essack, Magbubah, et al.
Publicado: (2012) -
Conotoxins: Therapeutic Potential and Application
por: Layer, Richard T., et al.
Publicado: (2006) -
α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia
por: Kennedy, Adam C., et al.
Publicado: (2020)